Medpace Holdings (MEDP) Return on Capital Employed (2016 - 2026)

Medpace Holdings has reported Return on Capital Employed for 11 years, with the latest figure at 79.56% in Q1 2026.

• For the quarter ending Q1 2026, Return on Capital Employed rose 2752.0% year-over-year to 79.56%; the trailing twelve-month figure through Mar 2026 stood at 79.56% (up 2752.0% YoY), and the FY2025 full-year result was 77.03%, up 1932.0% from the prior year.
• Return on Capital Employed for Q1 2026 stood at 79.56%, down from 102.77% in the prior quarter.
• The five-year high for Return on Capital Employed was 133.99% in Q3 2025, with the low at 23.32% in Q1 2022.
• Historically, Return on Capital Employed has averaged 61.36% across 5 years, with a median of 52.04% in 2025.
• Annual changes were most pronounced in 2024 — Return on Capital Employed plunged 1501 bps — and 2025, when it jumped 9143 bps.
• Medpace Holdings' Return on Capital Employed stood at 51.9% in 2022, then climbed by 0 bps to 52.09% in 2023, then decreased by 13 bps to 45.23% in 2024, then jumped by 127 bps to 102.77% in 2025, then declined by 23 bps to 79.56% in 2026.
• The last three Return on Capital Employed figures came in at 79.56% (Q1 2026), 102.77% (Q4 2025), and 133.99% (Q3 2025), per Business Quant data.